Sankha Pattanayak

Sankha is a chemical biologist with research experience in the interface of oligonucleotide chemistry and cell and developmental biology. Prior to Creyon, he served as Principal Investigator of Oligonucleotides at Syngene International Ltd (a Biocon Company) in Bangalore. He received his Masters degree in Chemistry from Indian Institute of Technology, Roorkee and a Ph.D. in Bioorganic Chemistry from the Indian Association for the Cultivation of Science, Kolkata. Sankha subsequently received his postdoctoral training at the University of Colorado Boulder and Stanford University School of Medicine. He has published eighteen research articles and has four granted United States patents to his credit. His research interests leverage the power of synthetic chemistry to invent new molecules that can be used to treat previously ‘undruggable’ genetic diseases.